PMC:7600245 / 32862-33028 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T128","span":{"begin":69,"end":72},"obj":"Body_part"}],"attributes":[{"id":"A128","pred":"fma_id","subj":"T128","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"k of the central phenyl-propanol moiety, a key structural feature of HIV protease inhibitors.\nDarunavir/cobicistat is under clinical investigation for the treatment o"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T297","span":{"begin":41,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"k of the central phenyl-propanol moiety, a key structural feature of HIV protease inhibitors.\nDarunavir/cobicistat is under clinical investigation for the treatment o"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T486","span":{"begin":17,"end":23},"obj":"Chemical"},{"id":"T487","span":{"begin":69,"end":92},"obj":"Chemical"},{"id":"T488","span":{"begin":73,"end":92},"obj":"Chemical"},{"id":"T490","span":{"begin":82,"end":92},"obj":"Chemical"},{"id":"T491","span":{"begin":94,"end":103},"obj":"Chemical"},{"id":"T492","span":{"begin":104,"end":114},"obj":"Chemical"}],"attributes":[{"id":"A486","pred":"chebi_id","subj":"T486","obj":"http://purl.obolibrary.org/obo/CHEBI_30396"},{"id":"A487","pred":"chebi_id","subj":"T487","obj":"http://purl.obolibrary.org/obo/CHEBI_35660"},{"id":"A488","pred":"chebi_id","subj":"T488","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A489","pred":"chebi_id","subj":"T488","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A490","pred":"chebi_id","subj":"T490","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A491","pred":"chebi_id","subj":"T491","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"},{"id":"A492","pred":"chebi_id","subj":"T492","obj":"http://purl.obolibrary.org/obo/CHEBI_72291"}],"text":"k of the central phenyl-propanol moiety, a key structural feature of HIV protease inhibitors.\nDarunavir/cobicistat is under clinical investigation for the treatment o"}

{"project":"LitCovid-PubTator","denotations":[{"id":"941","span":{"begin":17,"end":32},"obj":"Chemical"},{"id":"970","span":{"begin":94,"end":114},"obj":"Chemical"}],"attributes":[{"id":"A941","pred":"tao:has_database_id","subj":"941","obj":"MESH:C439395"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"k of the central phenyl-propanol moiety, a key structural feature of HIV protease inhibitors.\nDarunavir/cobicistat is under clinical investigation for the treatment o"}